The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43

Clinical Genetics

Volumn 83, Issue 4, 2013, Pages 321-331

  Hodgkinson, K A ^a   Connors, S P ^b   Merner, N ^a   Haywood, A ^a   Young, T L ^a   Mckenna, W J ^c   Gallagher, B ^d   Curtis, F ^a   Bassett, A S ^e   Parfrey, P S ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d James Paton Memorial Hospital   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

ARVC; Autosomal dominant; Cohort; DCM; Founder; SCD; TMEM43

Indexed keywords

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECTOPIA CORDIS; FAINTNESS; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HEART RIGHT VENTRICLE DYSPLASIA; HOLTER MONITOR; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; R WAVE; THORAX PAIN; TMEM43 GENE; AGED; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ELECTROCARDIOGRAPHY; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PEDIGREE; PROCEDURES; VERY ELDERLY;

MEMBRANE PROTEIN; TMEM43 PROTEIN, HUMAN;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE;

EID: 84874952154     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2012.01919.x     Document Type: Article

References (30)

1. Ellinor PT, MacRae CA, Thierfelder L. Arrhythmogenic right ventricular cardiomyopathy. Heart Fail Clin 2010: 6: 161-177.
2. Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur Heart J 2010: 31: 806-814.
3. Johns Hopkins, from http://www.hopkinsmedicine.org/heart_vascular_institute/clinical_services/arvd/_pdf/arvd_checklist_comparison.pdf. Baltimore, 2010. Accessed on June, 2012.
4. Guiraudon G, Klein G, Gulaumshein S et al. Total disconnection of right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation 1983: 67: 463-470.
5. Fontaine G, Guiraudon G, Frank R et al. Stimulation studies and epicardial mapping in VT: study of mechanisms and selection for surgery. In: Kulbertus H, ed. Reentrant arrhythmias. Lancaster, PA: MTP Publishers, 1977: 334-350.
6. Marcus F, Fontaine G, Guiraudon G. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982: 65: 384-398.
7. McKenna WJ, Thiene G, Nava A et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial disease of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994: 71: 215-218.
8. Hamid MS, Norman M, Quraishi A et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002: 40: 1445-1450.
9. Ahmad F, Li D, Karibe A et al. Localisation of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 1998: 98: 2791-2795.
10. Hodgkinson K, Dicks E, Connors S et al. Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland & Labrador: lessons for health policy in genetic disease. Genet Med 2009: 11: 859-865.
11. Merner ND, Hodgkinson KA, Haywood AF et al. Arrhythmogenic right ventricular cardiomyopathy type 5 (ARVD5) is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 2008: 82: 809-821.
12. Bengtsson L, Otto H. LUMA interacts with Emerin and influences its distribution at the inner nuclear membrane. J Cell Sci 2008: 121: 536-548.
13. Blomstrom-Lundqvist C, Sabel K, Olsson S. A long term follow-up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987: 58: 477-488.
14. Marcus FI, Fontaine GH, Frank R et al. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 1989: 10: 68-73.
15. Pinamonti B, Di Lenarda A, Sinagra G et al. Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group. Am Heart J 1995: 129: 412-415.
16. Hodgkinson K, Parfrey P, Bassett A et al. The impact of implantable cardioverter defibrillator therapy on survival in autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005: 45: 400-408.
17. Gami AS, Holly TA, Rosenthal JE. Electrocardiographic poor R-wave progression: analysis of multiple criteria reveals little usefulness. Am Heart J 2004: 148: 80-85.
18. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980: 62: 1054-1061.
19. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
20. Hodgkinson K. The clinical and genetic epidemiology of ARVC in Newfoundland. Clinical Epidemiology. Ph.D. thesis. St. John's: Memorial University, 2009.
21. Henry WL, Ware J, Gardin JM et al. Echocardiographic measurements in normal subjects. Growth related changes that occur between infancy and early adulthood. Circulation 1978: 57: 278-285.
22. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston, MA: Little, Brown & Co, 1994.
23. Bauce B, Basso C, Rampazzo A et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005: 16: 1666-1675.
24. Hulot J, Jouven X, Empana J et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004: 110: 1879-1884.
25. Zema MJ, Kligfield P. Electrocardiology poor R wave progression II: correlation with angiography. J Electrocardiol 1979: 12: 11-15.
26. Fatkin D, MacRae C, Sasaki T et al. Missense mutations in the rod domain of the Lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med 1999: 341: 1715-1724.
27. Mounkes LC, Kozlov SV, Rottman JN et al. Expression of an LMNA-N195K variant of A-type Lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 2005: 14: 2167-2180.
28. Nava A, Bauce B, Basso C et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000: 36: 2226-2233.
29. Shen X, Hodgkinson K, Parfrey P et al. Ten-year follow-up of mortality in an ARVD5 cohort after ICD therapy. Canadian Cardiovascular Congress, Montreal, 2010.
30. Sen-Chowdhry S, Morgan RD, Chambers JC et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010: 61: 233-253.